20190701/rcv_accession//created/000000000000:55060:{"variation_id":"7884","id":"RCV000778139","variation_archive_id":"VCV000007884","date_last_evaluated":"2019-04-05","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND ABCA4-Related Disorders","submission_count":"1","trait_set_id":"33431","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
20190701/rcv_accession//created/000000000000:152110:{"variation_id":"7884","id":"RCV000504806","variation_archive_id":"VCV000007884","date_last_evaluated":"2015-01-01","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone/cone-rod dystrophy","submission_count":"1","trait_set_id":"33742","review_status":"no assertion criteria provided","interpretation":"Likely pathogenic"}
20190701/rcv_accession//created/000000000000:464597:{"variation_id":"7884","id":"RCV000259072","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-11-17","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not specified","submission_count":"1","trait_set_id":"9590","review_status":"criteria provided, single submitter","interpretation":"Benign"}
20190701/rcv_accession//created/000000000000:603482:{"variation_id":"7884","id":"RCV000393726","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Macular degeneration","submission_count":"1","trait_set_id":"33398","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
20190701/rcv_accession//created/000000000000:608659:{"variation_id":"7884","id":"RCV000285333","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone-Rod Dystrophy, Recessive","submission_count":"1","trait_set_id":"33383","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
20190701/rcv_accession//created/000000000000:611349:{"variation_id":"7884","id":"RCV000393715","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis Pigmentosa, Recessive","submission_count":"1","trait_set_id":"33382","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
20190701/rcv_accession//created/000000000000:624497:{"variation_id":"7884","id":"RCV000340261","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-06-14","version":"1","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt Disease, Recessive","submission_count":"1","trait_set_id":"33430","review_status":"criteria provided, single submitter","interpretation":"Likely benign"}
20190701/rcv_accession//created/000000000000:676391:{"variation_id":"7884","id":"RCV000008335","variation_archive_id":"VCV000007884","date_last_evaluated":"2016-01-01","version":"6","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt disease 1","submission_count":"2","trait_set_id":"1448","review_status":"criteria provided, single submitter","interpretation":"Likely pathogenic"}
20190701/rcv_accession//created/000000000000:700122:{"variation_id":"7884","id":"RCV000078671","variation_archive_id":"VCV000007884","date_last_evaluated":"2018-11-07","version":"7","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","submission_count":"2","trait_set_id":"9460","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance"}
20190731/rcv_accession//created/000000000000:233:{"date_last_evaluated":"2018-04-01","id":"RCV000787769","version":"1","trait_set_id":"6496","variation_archive_id":"VCV000007884","submission_count":"1","interpretation":"Pathogenic","title":"NM_000350.2(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis pigmentosa","variation_id":"7884","review_status":"no assertion criteria provided"}
20190902/rcv_accession//updated/000000000000:20283:{"id":"RCV000259072","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not specified","interpretation":"Benign","trait_set_id":"9590","date_last_evaluated":"2016-11-17","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:73016:{"id":"RCV000787769","variation_id":"7884","review_status":"no assertion criteria provided","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis pigmentosa","interpretation":"Pathogenic","trait_set_id":"6496","date_last_evaluated":"2018-04-01","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:191255:{"id":"RCV000393715","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinitis Pigmentosa, Recessive","interpretation":"Likely benign","trait_set_id":"33382","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:191387:{"id":"RCV000285333","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone-Rod Dystrophy, Recessive","interpretation":"Likely benign","trait_set_id":"33383","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:191764:{"id":"RCV000393726","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Macular degeneration","interpretation":"Likely benign","trait_set_id":"33398","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:192920:{"id":"RCV000340261","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt Disease, Recessive","interpretation":"Likely benign","trait_set_id":"33430","date_last_evaluated":"2016-06-14","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:205508:{"id":"RCV000008335","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt disease 1","interpretation":"Likely pathogenic","trait_set_id":"1448","date_last_evaluated":"2016-01-01","version":"6","variation_archive_id":"VCV000007884","submission_count":"2"}
20190902/rcv_accession//updated/000000000000:226053:{"id":"RCV000504806","variation_id":"7884","review_status":"no assertion criteria provided","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Cone/cone-rod dystrophy","interpretation":"Likely pathogenic","trait_set_id":"33742","date_last_evaluated":"2015-01-01","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20190902/rcv_accession//updated/000000000000:319545:{"id":"RCV000078671","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","interpretation":"Uncertain significance","trait_set_id":"9460","date_last_evaluated":"2018-11-07","version":"7","variation_archive_id":"VCV000007884","submission_count":"2"}
20190902/rcv_accession//updated/000000000000:388397:{"id":"RCV000778139","variation_id":"7884","review_status":"criteria provided, single submitter","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND ABCA4-Related Disorders","interpretation":"Uncertain significance","trait_set_id":"33431","date_last_evaluated":"2019-04-05","version":"1","variation_archive_id":"VCV000007884","submission_count":"1"}
20191231/rcv_accession//updated/000000000000:13870:{"id":"RCV000078671","variation_id":"7884","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","submission_count":"3","interpretation":"Conflicting interpretations of pathogenicity","variation_archive_id":"VCV000007884","review_status":"criteria provided, conflicting interpretations","trait_set_id":"9460","version":"8","date_last_evaluated":"2019-02-26"}
20200203/rcv_accession//updated/000000000000:30353:{"review_status":"criteria provided, conflicting interpretations","variation_id":"7884","variation_archive_id":"VCV000007884","trait_set_id":"9460","interpretation":"Conflicting interpretations of pathogenicity","version":"9","submission_count":"4","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","date_last_evaluated":"2019-02-26","id":"RCV000078671"}
20200203/rcv_accession//updated/000000000000:32069:{"review_status":"criteria provided, conflicting interpretations","variation_id":"7884","variation_archive_id":"VCV000007884","trait_set_id":"1448","interpretation":"Conflicting interpretations of pathogenicity","version":"7","submission_count":"3","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Stargardt disease 1","date_last_evaluated":"2019-05-28","id":"RCV000008335"}
20200302/rcv_accession//updated/000000000000:10198:{"version":"2","id":"RCV000259072","submission_count":"2","review_status":"criteria provided, conflicting interpretations","variation_archive_id":"VCV000007884","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not specified","variation_id":"7884","interpretation":"Conflicting interpretations of pathogenicity","date_last_evaluated":"2019-04-09","trait_set_id":"9590"}
20200506/rcv_accession//created/000000000000:42452:{"version":"1","date_last_evaluated":"2019-03-07","submission_count":"1","review_status":"criteria provided, single submitter","interpretation":"Uncertain significance","variation_id":"7884","variation_archive_id":"VCV000007884","trait_set_id":"12366","id":"RCV001075661","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND Retinal dystrophy"}
20200506/rcv_accession//updated/000000000000:189004:{"date_last_evaluated":"2019-12-31","review_status":"criteria provided, conflicting interpretations","variation_archive_id":"VCV000007884","version":"10","submission_count":"4","trait_set_id":"9460","interpretation":"Conflicting interpretations of pathogenicity","variation_id":"7884","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","id":"RCV000078671"}
20200602/rcv_accession//updated/000000000000:18899:{"id":"RCV000078671","variation_archive_id":"VCV000007884","version":"11","review_status":"criteria provided, conflicting interpretations","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","date_last_evaluated":"2019-12-31","interpretation":"Conflicting interpretations of pathogenicity","submission_count":"4","trait_set_id":"9460","variation_id":"7884"}
